powered by LeadingAge New York

Outpatient Therapeutics

January 31, 2023

Outpatient Therapeutics

DOH Issues Revised Guidance on COVID-19 Treatment Recommendations

Members encouraged to share information with their medical directors and physicians.

Read More
Tags: COVID-19
January 26, 2023

Outpatient Therapeutics

DOH Advisory: Updates on COVID-19 Treatment Recommendations
Read More
Tags: COVID-19
November 30, 2022

Outpatient Therapeutics

DOH Advisory: Updates on COVID-19 Treatment Recommendations
Read More
Tags: COVID-19
May 31, 2022

Outpatient Therapeutics

DOH Issues Health Advisory Regarding Paxlovid Use

Advisory relates to use of Paxlovid and potential for rebound COVID-19 after treatment.

Read More
Tags: COVID-19
May 24, 2022

Outpatient Therapeutics

DOH Advisory: COVID-19 Rebound After Paxlovid Treatment
Read More
Tags: COVID-19
April 25, 2022

Outpatient Therapeutics

Access to COVID-19 Therapeutics: Reminders for Nursing Homes

Nursing homes that operate their own pharmacy must enroll in a specialized system to request monoclonal antibody therapies and may request oral antivirals by sending a request to covid19therapeutics@health.ny.gov or through the Health Partner Order Portal. Nursing homes that do not operate their own pharmacy may access therapeutics through their LTC pharmacy.

Read More
April 19, 2022

Outpatient Therapeutics

DOH Advisory: COVID-19 Oral Antiviral Treatment Available
Read More
Tags: COVID-19
March 29, 2022

Outpatient Therapeutics

DOH Issues Advisory on Pause in Distribution of Sotrovimab

Currently authorized alternative treatments, including Paxlovid, molnupiravir, and bebtelovimab, available for distribution.

Read More
Tags: COVID-19
March 25, 2022

Outpatient Therapeutics

DOH Advisory: Pause in Distribution of Sotrovimab
Read More
Tags: COVID-19
March 4, 2022

Outpatient Therapeutics

DOH Advisory: Test Soon and Treat Early to Improve Outcomes from COVID-19
Read More
Tags: COVID-19
  • view more